Glucagon-like peptide-2 receptor: Difference between revisions

From WikiMD's Wellness Encyclopedia

CSV import
Tags: mobile edit mobile web edit
CSV import
 
Line 23: Line 23:
{{medicine-stub}}
{{medicine-stub}}
{{No image}}
{{No image}}
__NOINDEX__

Latest revision as of 13:34, 17 March 2025

Glucagon-like peptide-2 receptor (GLP-2R) is a protein that in humans is encoded by the GLP2R gene. It is a member of the glucagon receptor family of G protein-coupled receptors.

Function[edit]

The GLP-2R is a receptor for the glucagon-like peptide 2 (GLP-2). Upon binding, GLP-2 stimulates intestinal growth and upregulates villus height in the small intestine, increases nutrient absorption and reduces inflammation. It is an important factor in the intestinal adaptation that occurs in response to the resection of the small intestine.

Clinical significance[edit]

Mutations in the GLP2R gene are associated with a rare congenital disorder of gastrointestinal absorption. This disorder, known as intestinal pseudo-obstruction, is characterized by abnormalities in the nerves of the intestines, leading to severe digestive problems.

GLP-2R is also a potential therapeutic target for inflammatory bowel disease (IBD) and short bowel syndrome (SBS). GLP-2 analogs that activate the GLP-2R have been shown to improve intestinal function in patients with these conditions.

See also[edit]

References[edit]

<references />


This GPCR-related article is a stub. You can help WikiMD by expanding it.

This article is a stub related to genetics. You can help WikiMD by expanding it!


Stub icon
   This article is a medical stub. You can help WikiMD by expanding it!